Speaker Bio
Max, a Master of Research (MRs) in Developmental Neuroscience and Psychopathology, has a passion for clinical research and integrative treatments. He’s worked on various research projects, including ketamine treatment for suicidality at Yale University and neuroscientific research into the mechanistic action of psychedelic drugs at Lubeck University. Currently, Max is involved in innovative research with Onaya Science, investigating the ceremonial use of ayahuasca on mental health outcomes in Military Veterans with PTSD. Regarding clinical practice, Max offers cognitive behavioural hypnotherapy for stress and anxiety, and therapeutic massage for the UK National Health Service (NHS). Max integrates these modalities into a more holistic mind & body therapy service; with plans to help establish a multidisciplinary clinic, delivering a range of treatments and self-care education informed by his research.
ICPR 2024 Abstract
Ayahuasca's Impact on Veterans with PTSD in a Traditional Framework – Insights from a 6-Month Follow-up Study
Onaya Science has researched the impact of traditional Shipibo-led ayahuasca ceremonies on mental health since 2016, with ongoing neuroscientific, psychological and biological research into Military Veterans with PTSD. This presentation reports promising preliminary results from a 6-month follow-up pilot study and highlights the necessity for culturally sensitive and ethical research to recognize the impact of these traditional psychedelic practices.
The pilot study consisted of ten Military Veterans with PTSD undergoing five Shipibo-led ayahuasca ceremonies across ten days. Psychometrics, EEG, and pending epigenetic analysis were collected, with assessments at pre-treatment, post-treatment, and 6-month follow-ups.
As hypothesised, there were positive impacts on mental health outcomes post-treatment, as indicated by significant reductions in PTSD symptoms, depression, anxiety, impulsivity, and alcohol cravings. Regarding EEG results, alterations in neural activity post-retreat indicated positive changes, reflecting increased brain flexibility and adaptability. 6-month follow-up results for psychometrics and EEG are due to be completed in two weeks. While epigenetic analysis is pending, our previous research suggests that attention to candidate genes, like SIGMAR1, warrants attention.
These findings underscore the importance of further research into these traditional practices. By better understanding the impact of these traditional practices through scientific exploration, we can begin to recognise and appreciate the accumulation of knowledge embedded in psychedelic practices that predate psychiatry considerably. However, it is imperative to approach such research with utmost care, steering clear of exploitation and appropriation of cultures, values, and traditions. Onaya Science is committed to cultural sensitivity and ethical considerations, exemplified through collaboration and reciprocity with indigenous healers. All of which will be highlighted in the presentation.